These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6047709)

  • 1. Phosphorus analogs of sulfonylureas. Sodium N-carbamoylphonamidates.
    Fanshawe WJ; Bauer VJ; Safir SR
    J Med Chem; 1967 Jan; 10(1):116-7. PubMed ID: 6047709
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].
    Hasselblatt A; Panten U; Poser W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1483-7. PubMed ID: 5394471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphinylguanidines. Phosphorus analogs of biguanides.
    Fanshawe WJ; Bauer VJ
    J Med Chem; 1967 Mar; 10(2):273. PubMed ID: 6034079
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insulin liberation from the pancreas by sulfonylurea].
    Pfaff W; Schöne HH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1445-8. PubMed ID: 4899084
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
    Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of potential antineoplastic agents. 35. Phosphorus-containing structural analogs of myleran.
    Struck RF
    J Med Chem; 1966 Mar; 9(2):231-4. PubMed ID: 5911803
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of HB 419 on exogenous and endogenous insulin in dogs and rabbits].
    Pfaff W; Schröder HG
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1488-91. PubMed ID: 5394472
    [No Abstract]   [Full Text] [Related]  

  • 10. A NEW HYPOGLYCEMIC COMPOUND, 1-CYCLOHEXYL-3-(5-INDANYLSULFONYL) UREA.
    LERNER LJ; BIANCHI A; BORMAN A
    Metabolism; 1965 May; 14():578-82. PubMed ID: 14289483
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of isocyanates by fragmentation of sulfonylureas.
    Ulrich H; Sayigh AA
    Angew Chem Int Ed Engl; 1966 Aug; 5(8):724-5. PubMed ID: 4962478
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies between HB 419 (glibenclamide) and tolbutamide on their effect on insulin liberation in isolated islands of rat pancreas in vitro].
    Weinges KF; Biro G; Kettl H; Mitzuno M
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1467-9. PubMed ID: 4899089
    [No Abstract]   [Full Text] [Related]  

  • 15. Cis-1-[(2-piperidinocyclohexyl)carbonyl]-piperidine and related compounds. Oral hypoglycemic agents.
    Rynbrandt RH; Schmidt FL
    J Med Chem; 1971 Jan; 14(1):54-6. PubMed ID: 5539748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of blood sugar decreasing sulfonylureas on the in vitro metabolism of glucose and amino acids in the beta-cells of the pancreas in mice].
    Hellerström C; Westman S; Stork H; Schmidt FH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1464-7. PubMed ID: 4899088
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoglycemic cyclic amidines.
    Barsky LI; Bencze WL
    J Med Chem; 1971 Jan; 14(1):40-4. PubMed ID: 5539744
    [No Abstract]   [Full Text] [Related]  

  • 19. New potent blood sugar lowering compound.
    Gupta CM; Husain ST; Bhaduri AP; Khanna NM; Mukherjee SK
    Nature; 1969 Aug; 223(5205):524. PubMed ID: 5796959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.